Comparison of Femto LDV Z8 Corneal Lenticule Extraction for Advanced Refractive Correction (CLEAR) and Visumax Small Incision Lenticule Extraction (SMILE)
1 other identifier
observational
65
1 country
1
Brief Summary
This observational study aims to compare two laser corrective procedures for treating myopia and myopic astigmatism: a novel refractive technique, the CLEAR procedure, and the established SMILE procedure. Participants will be randomized to undergo CLEAR in one eye and SMILE in the other. The investigators will evaluate and compare the two procedures based on the following aspects: refractive predictability (how accurate the vision correction is) by measuring the proportion of eyes close to the target prescription after surgery, clinical dry eye outcomes, changes in tear proteins, and corneal nerve changes at 1, 3, 6, and 12 months after both surgeries. Metabolomic features of the removed corneal tissue and how precisely the laser is centered during surgery will also be examined. Our hypothesis is that CLEAR provides equally good vision results as SMILE, and explore any extra benefits of CLEAR.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Mar 2023
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 1, 2023
CompletedFirst Submitted
Initial submission to the registry
December 30, 2024
CompletedFirst Posted
Study publicly available on registry
January 14, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 31, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2025
CompletedJanuary 14, 2025
December 1, 2024
2.7 years
December 30, 2024
January 8, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Rate of refractive predictability
Refractive predictability is defined as the proportion number of eyes achieving a postoperative spherical equivalent (SE) within ±1.0 D of the intended target. Uncorrected visual acuity (UCVA), refraction, and best corrected visual acuity (BCVA) will be recorded.
1 year
Secondary Outcomes (14)
Level of higher order aberrations
1 year
Tear Break Up Time (TBUT)
1 year
Concentration of tear neuromediators assessed by enzyme-linked immunosorbent assay
1 year
Corneal sensitivity measurements assessed by Cochet-Bonnet esthesiometer
1 year
NEI score
1 year
- +9 more secondary outcomes
Study Arms (2)
1. CLEAR surgery eyes
Eyes that have undergone CLEAR procedures.
2. SMILE surgery eyes
Eyes that have undergone SMILE procedures.
Interventions
Routinely conducted procedure using FEMTO LDV Z8 laser system for correction of Myopia.
Routinely conducted procedure using VisuMax laser system for correction of Myopia.
Eligibility Criteria
A total of 65 subjects (130 eyes- 65 CLEAR eyes and 65 SMILE eyes) will be recruited in the study from refractive clinic at Singapore National Eye Centre.
You may qualify if:
- \>/= 21 years of age and \</= 50 years of age.
- Cycloplegic spherical equivalent of \>-1.00D
- Refractive cylinder -2.00 D or less; anisometropia \<1.00D
- Best spectacle corrected visual acuity (BSCVA) of 6/12 or better in BOTH eyes.
- Spherical or cylindrical error has progressed at -0.50D or less per year from date of baseline measurement.
- Contact lens wearers must have removed contact lenses at least two (2) weeks before the baseline measurement.
- No evidence of irregular astigmatism on corneal topography.
- Available to attend post-operative examinations for a 12-month period.
You may not qualify if:
- Progressive or unstable myopia and/or astigmatism.
- Clinical or corneal topographic evidence of keratoconus.
- Patients who want bilateral SMILE procedure
- Patients who want extracted corneal lenticule to be stored for future refractive surgery.
- Residual, recurrent or active ocular disease such as uveitis, severe dry eyes, severe allergic eye disease, glaucoma, visually significant cataract and retinal disease.
- Previous corneal surgery or trauma within the corneal treatment zone.
- Corneal vascularisation within 1mm of the corneal treatment zone.
- Taking systemic medications likely to affect wound healing, such as corticosteroids and antimetabolites.
- Systemically immunocompromised.
- Systemic disease likely to affect wound healing, such as diabetes, connective tissue disease and severe atopy.
- Pregnant or nursing.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Singapore National Eye Centre
Singapore, S169856, Singapore
Related Publications (1)
Yu M, Liu C, Lee IXY, Hsu VW, Wong RKT, Anam A, Lim R, Mehta JS, Liu YC. Randomized controlled trial on corneal denervation, neuroinflammation and ocular surface in corneal lenticule extraction for advanced refractive correction (CLEAR) and small incision lenticule extraction (SMILE). Eye Vis (Lond). 2025 Apr 1;12(1):12. doi: 10.1186/s40662-025-00429-1.
PMID: 40165267DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Jodhbir S Mehta, MD, FRCS
Singapore National Eye Centre
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
December 30, 2024
First Posted
January 14, 2025
Study Start
March 1, 2023
Primary Completion
October 31, 2025
Study Completion
December 31, 2025
Last Updated
January 14, 2025
Record last verified: 2024-12
Data Sharing
- IPD Sharing
- Will not share